Monolithic user-activated transdermal therapeutic system
US4911707A · kind A · utility
103Cited by
20References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 1988 |
| Grant date | Mar 27, 1990 |
| Priority date | — |
| Expiry date | Aug 10, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/7092
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transdermal drug delivery system which is manufactured in a pre-activated state for at least one of storage stability, manufacture safety, user safety, or control of release characteristic considerations and which is activated by a patient (or other person applying the system to the patient) just prior to or immediately after applying the system to the patient's skin is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.